CHD4 and hepatocellular carcinoma: In the context of CHD4-targeting drugs, recently, Ch41, a novel inhibitor of CHD4, was shown to inhibit the growth of lung tumors and hepatocellular carcinomas in immunocompetent C57BL/6 mice, but it was impaired in immunodeficient C57BL/6 mice [107].